Home Oncology Immunotherapies

Immunotherapies

Latest
Lymphocytes attacking a cancer cell, illustration
Immunotherapies

BioNTech Continues U.S. Expansion Plans with Acquisition of Kite’s TCR Platform...

CART Cell Cancer Immunotherapy
Immunotherapies

Transcription Factor Extends Reach of Tumor-Fighting CAR-T Cells

Immunotherapies

Tumor Organoids Could Help Guide Immunotherapy for Appendiceal Cancer

Researchers at The University of Texas MD Anderson Cancer Center have found that a rare resistance mutation first thought to appear in melanoma (pictured) following treatment with a targeted therapy has instead turned out to be hiding in the tumor all along. [Definiens]
Immunotherapies

Novel Immunotherapy Combination Produces Durable Response in Untreated Metastatic Melanoma

Microbiotica will use its precision metagenomics microbiome platform in an up-to-$534 million-plus partnership with Genentech
Immunotherapies

Gut Microbes Affect Response to Checkpoint Inhibitors in Melanoma

Cell division in 3D organoids
Immunotherapies

Drug Activation of p53 Protein Boosts Anti-Tumor Immune Response

Electronic medicine to monitor and adjust human body signals
Immunotherapies

Response to Immunotherapy Predicted Via Machine Learning Methods

Lymphocytes attacking a cancer cell, illustration
Immunotherapies

Engineered CAR-Natural Killer Cell Immunotherapy Targets Cancer Cells, While Sparing Healthy...

White blood cells, T lymphocytes or natural killers T attack a cancerous or infected cell 3D rendering illustration isolated on black background. Science, medicine, biomedical research, immune system, oncology, biology concepts.
Immunotherapies

“Bad” Fat Hinders Killer T Cells’ Ability to Fight Cancer

Lymphocytes, illustration
Immunotherapies

Pathogen Orientation Key to T-Cell Therapy Activation

Load more

Featured

New Products

View More
Load more
Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up